US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

Inicio
Invertir
Acciones
Reino Unido
LSE
Crism Therapeutics Corporation (CRTX)
Crism Therapeutics Corporation (CRTX) Noticias

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRTX

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
03/06/2024	09:25	RNS Regulatory News	Crism Therapeutics Corporation Director Dealing	LSE:CRTX	Crism Therapeutics Corporation
31/05/2024	15:58	Alliance News	IN BRIEF: Crism has first day of trade on AIM after name change, buy	LSE:CRTX	Crism Therapeutics Corporation
31/05/2024	01:00	RNS Regulatory News	Crism Therapeutics Corporation Admission to Trading and First Day of Dealings	LSE:CRTX	Crism Therapeutics Corporation
18/12/2009	12:45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
20/11/2009	14:40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
16/11/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
13/11/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
04/11/2009	06:00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
21/10/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
03/09/2009	07:01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
03/09/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
20/07/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
15/07/2009	18:04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
08/07/2009	15:15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX
12/06/2009	15:35	Dow Jones News	UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
12/06/2009	14:28	Dow Jones News	FDA: Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
19/05/2009	15:01	PR Newswire (US)	Cornerstone Therapeutics Announces Management Change	NASDAQ:CRTX
07/05/2009	06:01	PR Newswire (US)	Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	NASDAQ:CRTX
07/05/2009	06:00	PR Newswire (US)	Cornerstone Therapeutics Reports First Quarter 2009 Financial Results	NASDAQ:CRTX
27/04/2009	07:00	PR Newswire (US)	Cornerstone Therapeutics to Host First Quarter 2009 Conference Call	NASDAQ:CRTX
13/01/2009	16:33	Dow Jones News	UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
13/01/2009	14:34	Dow Jones News	FDA: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
05/11/2008	07:00	PR Newswire (US)	Cornerstone Therapeutics Announces New Board of Directors	NASDAQ:CRTX
01/08/2006	09:00	PR Newswire (US)	Critical Therapeutics Files Controlled Release Formulation of Zileuton	NASDAQ:CRTX

Showing the most relevant articles for your search:LSE:CRTX

1

Gold vs US Dollar

Euro vs US Dollar

Deutsche Telekom (QX)

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones